Movatterモバイル変換


[0]ホーム

URL:


US3900028A - Injection site for sterile medical liquid container - Google Patents

Injection site for sterile medical liquid container
Download PDF

Info

Publication number
US3900028A
US3900028AUS445852AUS44585274AUS3900028AUS 3900028 AUS3900028 AUS 3900028AUS 445852 AUS445852 AUS 445852AUS 44585274 AUS44585274 AUS 44585274AUS 3900028 AUS3900028 AUS 3900028A
Authority
US
United States
Prior art keywords
tube
diaphragm
retainer
rigid
flange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US445852A
Inventor
Charles J Mcphee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kendall Mcgraw Laboratories Inc
General Electric Co
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply CorpfiledCriticalAmerican Hospital Supply Corp
Priority to US445852ApriorityCriticalpatent/US3900028A/en
Priority to AU77044/74Aprioritypatent/AU481400B2/en
Priority to CA217,183Aprioritypatent/CA1017707A/en
Priority to DE19752501428prioritypatent/DE2501428A1/en
Priority to IT47776/75Aprioritypatent/IT1026410B/en
Priority to JP50021434Aprioritypatent/JPS5813418B2/en
Priority to GB739475Aprioritypatent/GB1465041A/en
Application grantedgrantedCritical
Publication of US3900028ApublicationCriticalpatent/US3900028A/en
Assigned to KENDALL MCGAW LABORATORIES, INC., A CORP OF OHreassignmentKENDALL MCGAW LABORATORIES, INC., A CORP OF OHASSIGNMENT OF ASSIGNORS INTEREST.Assignors: AMERICAN HOSPITAL SUPPLY CORPORATION, A CORP OF IL
Assigned to WELLS FARGO BANK, N.A.reassignmentWELLS FARGO BANK, N.A.SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: MCGAW, INC., A CORP. OF OH
Assigned to KENDALL MCGAW LABORATORIES, INC. AN OH CORPORATIONreassignmentKENDALL MCGAW LABORATORIES, INC. AN OH CORPORATIONRELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).Assignors: MANUFACTURERS HANOVER TRUST COMPANY
Assigned to KENDALL MCGAW LABORATORIES, INC.reassignmentKENDALL MCGAW LABORATORIES, INC.RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).Assignors: MANUFACTURERS HANOVER TRUST COMPANY
Assigned to MCGAW, INC., MORAINE, MONTGOMERY COUNTY, A CORP. OF OHreassignmentMCGAW, INC., MORAINE, MONTGOMERY COUNTY, A CORP. OF OHMERGER (SEE DOCUMENT FOR DETAILS). EFFECTIVE ON 10/22/1990 MAINEAssignors: MG ACQUISITION CORP. A CORP. OF DE (MERGED TO) KENDALL MCGAW LABORATORIES, INC., A CORP. OF OHIO
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, A NEW YORK CORP.reassignmentGENERAL ELECTRIC CAPITAL CORPORATION, A NEW YORK CORP.ASSIGNMENT OF ASSIGNORS INTEREST.Assignors: MCGAW, INC., A DELAWARE CORP.
Assigned to MCGAW, INC. A CORP. OF DELAWAREreassignmentMCGAW, INC. A CORP. OF DELAWARESECURITY INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: WELLS FARGO BANK, N.A.
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

An injection site for a parenteral liquid bottle with an improved structure and assembly method for securing a puncturable diaphragm to a closure of the bottle. The closure is formed with an integral upstanding tube that has an internal flange at its outer end. A rubber diaphragm and a tubular retainer are telescopically inserted into the upstanding tube from the tube''s inner end before the closure is assembled to the bottle. The retainer squeezes the diaphragm against an undersurface of the flange to form a seal and the retainer is locked in this position. After the closure is joined to the bottle, the entire joint between the upstanding tube and the retainer is inside the bottle and protected from external bacterial contamination.

Description

1 Aug. 19, 1975 1 1 INJECTION SITE FOR STERILE MEDICAL LIQUID CONTAINER [75] Inventor: Charles J. McPhee, Sylmar, Calif.
[73] Assignee: American Hospital Supply Corporation, Evanston, 111.
221 Filed: Feb. 26, 1974 211 Appl. No.: 445,852
[521 11.8. C1 128/272; 215/247 [51] Int. Cl. A611 H00 [58] Field of Search 128/272, 214 D, 214 C,
128/214 R, 214.2, DIG. 24, 227; 215/D1G. 3, 247253, 264, 292, 309, 200
Primary lituminer-Richard A. Gaudet Assistant Examiner-J. C. McGowan Attorney, Agent, or Firm-Larry N. Barger; Robert T. Merrick 5 7 ABSTRACT An injection site for a parenteral liquid bottle with an improved structure and assembly method for securing a puncturable diaphragm to a closure of the bottle. The closure is formed with an integral upstanding tube that has an internal flange at its outer end. A rubber diaphragm and a tubular retainer are telescopically inserted into the upstanding tube from the tubes inner end-before the closure is assembled to the bottle. The retainer squeezes the diaphragm against an undersurface of the flange to form a seal and the retainer is locked in this position. After the closure is joined to the bottle, the entire joint between the upstanding tube and the retainer is inside the bottle and protected from external bacterial contamination.
19 Claims, 8 Drawing Figures INJECTION SITE FOR STERILE MEDICAL LIQUID CONTAINER BAC KGROUND Sterile medical liquid such as parenteral solution is commonly infused into a patients vein from a container hanging above the patient. The sterile liquid flows by gravity through a tubular administration set connected at one end to the container and at an opposite end to a venous needle in the patient.
Sterile parenteral solutions, such as dextrose, normal saline, etc. are frequently supplied to the hospital in sealed sterilized containers. These containers are partially filled with liquid and have sterile air occupying the remainder of their volume. This is so that additive medication can be added to the air space of the container and mixed with the liquid of the bottle prior to administering to the patient. Many of the sterile medical liquid containers include what is termed as a injection site" through which these additive medications can be injected. The injection site includes a rubber diaphragm through which a hypodermic needle of a syringe or a pointed hollow spike of an additive container can be inserted. After withdrawal of the needle or spike the diaphragm reseals.
In the past these rubber diaphragms have been secured to the containers by a series of external clamping structures. These external clamps which included crimped metal rings, tape bands, etc.. compressively sealed the edges of the rubber diaphragm to the container structure.
When these external clamp members were not sufficiently crimped or tightened a small liquid seepage could occur at the edge of the puncturable rubber diaphragm. Such a small seepage in this area could be beneath the external clamp and hidden from view. Although many scientific tests are performed to determine there is no leakage or seepage in this area, it would be a definite advantage to have an additional visual test of any seepage.
SUMMARY OF THE INVENTION The present invention provides an improved injection site which requires no separate external clamping devices which might cause cracks. crevices, seams, etc. and where liquid seepage would be hidden from view. This invention provides an injection site structure that includes a rigid upstanding thermoplastic tube integrally formed with a thermoplastic inner closure of the bottle. This rigid tube has an integral inwardly extending thermoplastic flange at its outer end. Before the inner closure is assembled to the bottle a puncturable rubber diaphragm and a tubular retainer are preassembled. This diaphragm and retainer are telescopically inserted into an inner end of the upstanding tube and the retainer squeezingly compresses the rubber diaphragm against an under surface of the tubes integral flange to form a hermetic seal. With this structure the inner closure presents a homogenous mass of thermoplastic material of the inner closure. integral upstanding tube. and integral flange that externally supports the rubber diaphragm. There is no seam, cracks or crevices between the flange and upstanding tube. If there were any liquid seepage around the edge of the rubber diaphragm it would be readily visible on a top surface of the diaphragm. While such liquid seepage would be extremely rare, it is a definite advantage to visually see such seepage.
Other advantages of the improved injection site include three important structural advantages. First, the tubular retainer confines substantially all compressive forces against the rubber diaphragm in a direction parallel to the longitudinal axis of the upstanding tube so there is no substantially hoop compression on the edges of the diaphragm. Hoop compression used to seal prior rubber diaphragms to injection sites sometimes cause additional binding on the hypodermic needle puncturing the diaphragm. Secondly, the tubular retainer has a rigid puncture support collar that supports an underside of the diaphragm surrounding its principle puncturing target to prevent excessive downward deflection of the diaphragm during puncture. This prevents excessive distortion stresses from being transferred to the peripheral sealed area of the diaphragm. Thirdly, the puncture support collar fits into a recess on the underside of the diaphragm for aligning the diaphragm and the retainer prior to insertion of this preassembled unit into the rigid tube of the injection site.
THE DRAWINGS FIG. 1 is a front elevational view of the medical liquid container as it is supplied to the hospitals;
FIG. 2 is an enlarged perspective view of an upper end of the container showing its outer cap removed;
FIG. 3 is a top plan view of a puncturable resealable diaphragm portion of the injection site;
FIG. 4 is a sectional view taken along line 4-4 of FIG. 3.
FIG. 5 is an enlarged sectional view showing the method of assembling the injection site;
FIG. 6 is an enlarged sectional view of the injection site that has been assembled;
FIG. 7 is a further enlarged sectional view of the upper portion of the injection site showing the compressed edge of the diaphragm; and
FIG. 8 is a further enlarged sectional view of a lower portion of the injection site showing the means for locking the tube and retainer together.
DETAILED DESCRIPTION Referring to thesedrawings bottle 2 is shown in FIG. 1 having aneck 4 with an external flange 6. Secured to flange 6 is anouter cap 8 which houses the injection site. Thebottle 2 is supported by a series of feet such as 10 and 12 at its lower end. Betweenfeet 10 and I2 is arecess 14 that contains ahinged hanger 16. A front of the bottle has alabel 210 located between calibrations 21a and 21b.
Within the bottle is asterile liquid 18 and asterile gas 19, such as air. It is into thisair space 19 that an additive medication can be injected immediately prior to administering theliquid 18. It is to such an injection site that this invention relates.
In FIG. 2, the perspective view shows theouter cap 8 removed from the bottle to expose the inner cap and the injection site. This outer cap is shown frangibly connected to the bottle by a series of frangible webs. The precise details of this outer cap are described in my copending application entitled, Three Barrier Closure System for Medical Liquid Container," Ser. No. 445,834. Alternatively, this outer cap could be a frangible cap such as disclosed in a copending application entitled, Frangible Closure System for Medical Liquid Container and Method of Making Same," Ser. No. 338,685, invented by Pradip Choksi.
The inner closure of FIG. 2 includes atransverse wall 22 that is joined to anupstanding'collar 24 which is permanently sealed tocontainer neck collar 26. Integrally formed with the inner closuretransverse wall 22 is an upstanding rigidthermoplastic tube 28 that has an outlet structure for connecting to an administration set through which liquid is dispensed to the patient. Also integrally formed withtransverse wall 22 is a rigidupstanding tube 30 that forms a portion of the injection site structure which is indicated generally at 20.
Hermetically sealing off the outer end of both-rigid tubes 28 and 30 isa'thermoplastic metal foil 32 which is shown in FIG. 2. Thisfoil 32 is preferably in two portions so that the foil can be peeled back from either tube without interfering with the foils seal to the other tube. This foil onrigid tube 30 is peeled back immediately before use to expose a puncturableresealable diaphragm 34.
The puncturableresealable diaphragm 34, shown in the enlarged top view of FIG. 3, includes a peripheral sealingportion 36 and acentral puncture portion 38.Puncture portion 38 is surrounded by anupstanding target ring 40 that acts as a guide for locating the hypodermic needle or puncturing spike on the diaphragm. As shown in FIG. 4, thecentral puncturing area 38 is offset upwardly fromperipheral sealingportion 36 and thus forms arecess 42 in a bottom side of the diaphragm. The purpose ofrecess 42 and its relationship to a tubular retainer and puncturing support section will be explained later.
The construction of the injection site and method of assembly is shown in more detail in FIG. 5. Here,rigid tube 30 is clearly seen as have its lower end integrally formed withtransverse wall 22 of the inner closure. There are no seams, cracks, crevices, etc. betweenrigid tube 30 andtransverse wall 22. An upper end of the rigid tube has an integral inwardly extendingthermoplastic flange 44. This flange also has no joints, cracks, crevices, etc. between the flange andrigid tube 20. Theflange 44 has a beveled lead-insurface 46, a downardlydirecting sealing surface 48, and aninner surface 50. Thisinner surface 50 defines an opening through which the diaphragm can be punctured.
In the procedure for assembling the injection site thediaphragm 34 is fitted onto a rigidtubular retainer 52 to form a sub-assembly. Anupper end 54 of thetubular retainer 52 engagesperipheral portion 36 ofdiaphragm 34. The tubular retainer also includes a rigidpuncture support collar 56 that is supported bytransverse member 58. Abovetransverse member 58 is arecess 60 into which the squeezedperipheral portion 36 of the diaphragm is relieved when compressively sealed against undersurface 48 offlange 44.
FIG. shows how the rigidpuncture support collar 56 fits withinrecess 42 ofdiaphragm 34 to align the diaphragm with opening 50 of the flange ofrigid tube 30. The sub-assembly ofdiaphragm 34 andtubular retainer 52 is telescopically inserted into an inner end of the rigid tube until theperipheral section 36 of the diaphragm is tightly gripped between an upper end-54 of the retainer and an undersurface 48 offlange 44. When this occurs thediaphragm 34 takes on the configuration as shown in FIG. 6. Here theperipheral area 36 is tightly squeezed to form a hermetic seal and a portion of the squeezed diaphragm forms anannular bulge 62 that is relieved into annular recess of the re.- tainer. The diaphragm is sufficiently squeezed when the lower ends of the retainer and tube are in substantial alignment. At alower end 64 ofretainer 52 is anexternal recess 66. Aportion 68 of the lower end ofrigid tube 20 is deformed by heat and pressure to create an annular rib or flange that extends intorecess 66. There is also some deformation of the retainer at its lower end as shown in FIG. 8. This construction locks theretainer 52 intorigid tube 30 to continually squeeze the diaphragm against theunder surface 48 offlange 44.
At'the top of FIG. 6 the operation of therigid support collar 56 is shown during a needle puncture. Here therigid support collar 56 supports an area of the diaphragm immediately outward of thetarget ring 40. Thus, whenhypodermic needle 70 is forced throughdiaphragm 34,support collar 56 will prevent excessive strain and deflection of the diaphragm from being transmitted to the criticalhermetic seal area 36. Also in FIG. 6 the compressive forces onarea 36 ofdiaphragm 34 are substantially all in a direction parallel to alongitudinal axis 72 through the injection site. Thediaphragm 34 in this construction is relieved of inwardly directed hoop forces tending to laterally compress thediaphragm 34 againstcannular 70. Such hoop compression could cause the needle to bind as it passes throughdiaphragm 34. Some of the previous puncturable resealable diaphragms relied on a hoop compression around the peripheral of the diaphragm for making a seal with the closures.
FIG. 7 has a more detailed view that shows the compressedarea 36 ofdiaphragm 34 that is tightly squeezed betweensurface 48 andsurface 54 of the flange and'retainer respectively.
In FIG. 8 the enlarged sectional view at the bottom end of the injection site shows in more detail howrib 68 is deformed into the annular recess to lock tubular retainer to thetube 30.
The method of assembling the unique injection site of this invention includes placing thediaphragm 34 onretainer 52 and aligning it with the rigidpuncture support collar 56. Next the sub-assembly is telescopically inserted into a lower end opening ofrigid tube 20 as shown in FIG. 5 and moved intotube 20 untilperipheral section 36 of thediaphragm 34 is tightly compressed in a hermetic seal. Next the lower end ofrigid tube 20 is deformed by heat and pressure to form arib 68 that occupies at least a portion ofgroove 66 to lockretainer 52 torigid sleeve 20. The inner closure,diaphragm 34 andretainer 52 forms a unit that is next connected tothermoplastic metal foil 32.
After the foil has been attached, the inner closure is fitted to the neck of a liquid containingbottle 2. Then thecollar 24 and theinner closure 26 of the container are heat fused together. Finally theouter cap 8 is fitted over the inner closure and secured to the bottle flange by fusing a flange 9 of the closureto bottle flange 6.
It has been found that the above described invention works very well when the bottle, inner closure withintegral tubes 28 and 30, and tubular retainer are all made of a propylene-ethylene thermoplastic. Preferably, the puncturableresealable diaphragm 34 is of natural or synthetic rubber.
In the above description :1 specific embodiment has been used to illustrate the invention. However, it is understood that persons skilled in the art can make modifications to this embodiment without departing from the spirit and scope of the invention.
1 claim:
1. A container connected to a tube that has a puncturable resealable diaphragm secured within this tube, wherein the improvement comprises:
a container with a preformed opening therein; a closure with a rigid transverse wall spanning the container opening, with a periphery of the closure joined to the container at a hermetic seal; said transverse wall having an opening that is substantially smaller than the container opening and spaced from said hermetic seal; a rigid tube integrally formed with the transverse wall without any seam or joint therebetween, said tube having a passage communicating with the transverse wall opening; an inwardly extending flange integrally formed with the tube without any seam or joint therebetween; and a tubular retainer within said tube and spaced from said heremetic seal; said retainer, rigid tube, and flange combining to confine the diaphragm, and said retainer and flange engaging the diaphragm to form a hermetic seal whereby all external joints between the container and closure are remote from the diaphragm.
2. The combination as set forth in claim 1, wherein there is a locking means maintaining the retainer in a fixed relationship to the flange.
3. The combination as set forth inclaim 2, wherein said tube and retainer are rigid, and one of the tube and retainer has an annular groove and the other has a deformed section extending into said groove forming the locking means.
4. The combination as set forth in claim 3, wherein the retainer has one end portion that compressingly engages the puncturable resealable diaphragm and has an annular groove at an opposite end of the retainer, and said tube has an annular defonned bead extending into said groove.
5. The combination as set forth inclaim 4, wherein the closure including the tube has an inner surface adjacent the groove in the retainer; and said retainer has an inner end surface adjacent said groove, whereby alignment of the two inner surfaces insures a proper compression of the diaphragm between the flange and retainer.
6. The combination as set forth in claim I, wherein the rigid tube extends outwardly from the transverse thermoplastic wall.
7. The combination as set forth in claim 6, wherein the rigid tube has an outer end and the flange is adjacent this outer end.
8. The combination as set forth in claim 7, wherein the closure's transverse wall, outwardly extending rigid tube, and internal flange are formed of a homogeneous mass of thermoplastic material.
9. The combination as set forth in claim I, wherein the retainer includes a rigid puncture support member for a central portion of the puncturable resealable diaphragm.
10. The combination as set forth in claim 9. wherein the rigid puncture support member includes an annular collar engaging an inner surface of the diaphragm and the diaphragm has a peripheral area extending outwardly from the annular puncture support collar, and this peripheral area is hermetically sealed between the tubes flange and the retainer.
11. The combination as set forth inclaim 10, wherein the retainer has an annular recess between the rigid puncture support and an end portion of the retainer that compressingly squeezes the diaphragm against the flange, whereby the diaphragm can at least partially deform into said recess when its peripheral area is under compression.
12. The combination as set forth in claim 1], wherein the diaphragm has an upwardly offset central portion, and this offset portion is supported on its under surface by the rigid puncture support collar.
13. The combination as set forth inclaim 12, wherein the puncturable resealable diaphragm has an indicia indicating the location of a center passage through the rigid puncture support collar of the retainer.
14. The combination as set forth in claim 13, wherein the indicia is an upstanding ring on an outer surface of the diaphragm.
15. The combination as set forth in claim 1, wherein the flange is located at an outer end of the rigid tube and includes an inwardly beveled approach surface of the flange.
16. The combination as set forth in claim 1, wherein the puncturable resealable diaphragm is rubber.
17. The combination as set forth in claim 1, wherein the compressive forces on the puncturable resealable diaphragm are in a direction parallel to a longitudinal axis through the rigid tube.
18. The combination as set forth in claim 17, wherein the diaphragm is free of any substantial hoop compression.
19. An injection site structure connected to a sterile medical liquid container comprising: a rigid thermoplastic inner closure having a transverse wall hermetically sealed to an opening of the container; a rigid upstanding thermoplastic tube integrally formed with the transverse wall and extending upwardly from said transverse wall; an inwardly extending thermoplastic flange integrally formed with an upper end portion of the upstanding tube, said flange having a beveled leadin surface and an under surface; a rubber puncturable resealable diaphragm having an upwardly offset center portion and a peripheral sealing portion fitting within said tube and having an upper annular peripheral surface in abutting engagement with the under surface of said flange; a rigid thermoplastic tubular retainer fitting within said rigid upstanding tube and compressingly squeezing an annular peripheral portion of the rubber diaphragm into hermetic sealing engagement with the under surface of said flange; a rigid thermoplastic tubular retainer fitting within said rigid upstanding tube and compressingly squeezing an annular peripheral portion of the rubber diaphragm into hermetic sealing engagement with the under surface of the flange; a locking means securing the retainer in a fixed position within said upstanding tube; a peelable foil secured to an outer end of said upstanding tube; and an outer cap fitting over said upstanding tube and foil, said outer cap being frangibly secured to the bottle.

Claims (19)

1. A container connected to a tube that has a puncturable resealable diaphragm secured within this tube, wherein the improvement comprises: a container with a preformed opening therein; a closure with a rigid transverse wall spanning the container opening, with a periphery of the closure joined to the container at a hermetic seal; said transverse wall having an opening that is substantially smaller than the container opening and spaced from said hermetic seal; a rigid tube integrally formed with the transverse wall without any seam or joint therebetween, said tube having a passage communicating with the transverse wall opening; an inwardly extending flange integrally formed with the tube without any seam or joint therebetween; and a tubular retainer within said tube and spaced from said heremetic seal; said retainer, rigid tube, and flange combining to confine the diaphragm, and said retainer and flange eNgaging the diaphragm to form a hermetic seal whereby all external joints between the container and closure are remote from the diaphragm.
19. An injection site structure connected to a sterile medical liquid container comprising: a rigid thermoplastic inner closure having a transverse wall hermetically sealed to an opening of the container; a rigid upstanding thermoplastic tube integrally formed with the transverse wall and extending upwardly from said transverse wall; an inwardly extending thermoplastic flange integrally formed with an upper end portion of the upstanding tube, said flAnge having a beveled lead-in surface and an under surface; a rubber puncturable resealable diaphragm having an upwardly offset center portion and a peripheral sealing portion fitting within said tube and having an upper annular peripheral surface in abutting engagement with the under surface of said flange; a rigid thermoplastic tubular retainer fitting within said rigid upstanding tube and compressingly squeezing an annular peripheral portion of the rubber diaphragm into hermetic sealing engagement with the under surface of said flange; a rigid thermoplastic tubular retainer fitting within said rigid upstanding tube and compressingly squeezing an annular peripheral portion of the rubber diaphragm into hermetic sealing engagement with the under surface of the flange; a locking means securing the retainer in a fixed position within said upstanding tube; a peelable foil secured to an outer end of said upstanding tube; and an outer cap fitting over said upstanding tube and foil, said outer cap being frangibly secured to the bottle.
US445852A1974-02-261974-02-26Injection site for sterile medical liquid containerExpired - LifetimeUS3900028A (en)

Priority Applications (7)

Application NumberPriority DateFiling DateTitle
US445852AUS3900028A (en)1974-02-261974-02-26Injection site for sterile medical liquid container
AU77044/74AAU481400B2 (en)1974-02-261974-12-31Injection site for sterile medical liquid container
CA217,183ACA1017707A (en)1974-02-261974-12-31Injection site for sterile medical liquid container and method of assembling same
DE19752501428DE2501428A1 (en)1974-02-261975-01-15 CONTAINER FOR MEDICAL LIQUIDS
IT47776/75AIT1026410B (en)1974-02-261975-01-21 IMPROVEMENT IN CONTAINERS FOR STERILE SOLUTIONS
JP50021434AJPS5813418B2 (en)1974-02-261975-02-20 container
GB739475AGB1465041A (en)1974-02-261975-02-21Closure provided with an injection site for sealing the outlet of a medical liquid container

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US445852AUS3900028A (en)1974-02-261974-02-26Injection site for sterile medical liquid container

Publications (1)

Publication NumberPublication Date
US3900028Atrue US3900028A (en)1975-08-19

Family

ID=23770453

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US445852AExpired - LifetimeUS3900028A (en)1974-02-261974-02-26Injection site for sterile medical liquid container

Country Status (6)

CountryLink
US (1)US3900028A (en)
JP (1)JPS5813418B2 (en)
CA (1)CA1017707A (en)
DE (1)DE2501428A1 (en)
GB (1)GB1465041A (en)
IT (1)IT1026410B (en)

Cited By (48)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4013064A (en)*1975-06-261977-03-22The Kendall CompanyPort means for a liquid transport system
US4219912A (en)*1978-10-101980-09-02Baxter Travenol Laboratories, Inc.Injection site having thermoplastically sealed injection port
US4294249A (en)*1979-10-181981-10-13Cutter Laboratories, Inc.Swage-molded injection site
US4307766A (en)*1979-05-181981-12-29Terumo CorporationPlastic container for medical liquid
US4361253A (en)*1980-08-041982-11-30Instrumentation Laboratory Inc.Liquid transfer device
US4416661A (en)*1981-12-241983-11-22Cutter Laboratories, Inc.Injection site for fluids
WO1985004097A1 (en)*1984-03-131985-09-26Christensen John FAn appliance for the preparation of injectable medicaments
US4601703A (en)*1984-01-271986-07-22Intermedicat GmbhInjector for an infusion or transfusion system
US4665959A (en)*1984-10-151987-05-19Terumo Kabushiki KaishaPlug assembly
FR2618682A1 (en)*1987-07-301989-02-03Aguettant LabDevice for closing and connecting containers for infusion liquids
WO1989002399A1 (en)*1987-09-101989-03-23Joseph Parsons Nominees Pty. Ltd.Cap
US4892222A (en)*1988-11-251990-01-09Baxter International Inc.Port assembly for a container
US4941517A (en)*1988-10-201990-07-17Galloway TrustAseptic fluid transfer apparatus and methods
WO1991010459A1 (en)*1990-01-101991-07-25Angeion CorporationHemostasis valve introducer
US5086783A (en)*1990-10-311992-02-11Sherwood Medical CompanyBlood sampling device
US5086813A (en)*1988-10-201992-02-11Galloway Edwin JAseptic fluid transfer methods
US5088995A (en)*1990-06-221992-02-18Baxter International Inc.Port and closure assembly including a resealing injection site for a container
US5188620A (en)*1988-01-251993-02-23Baxter International Inc.Pre-slit injection site and associated cannula
US5199473A (en)*1988-10-201993-04-06Galloway TrustAseptic fluid transfer apparatus and methods
US5199948A (en)*1991-05-021993-04-06Mcgaw, Inc.Needleless valve
US5211638A (en)*1988-01-251993-05-18Baxter International Inc.Pre-slit injection site
US5246434A (en)*1991-04-261993-09-21Nissho CorporationBlood collecting tube
US5269350A (en)*1988-10-201993-12-14Galloway CompanyAseptic fluid transfer apparatus and methods
US5343900A (en)*1988-10-201994-09-06Galloway CompanyNeedle bundle driver and methods
EP0721897A1 (en)*1995-01-101996-07-17Pohl GmbH & Co. KGDevice for infusion bottles or the like
US5658260A (en)*1988-01-251997-08-19Baxter International Inc.Bayonet lock cannula for pre-slit y-site
US5776125A (en)*1991-07-301998-07-07Baxter International Inc.Needleless vial access device
US5797897A (en)*1988-01-251998-08-25Baxter International Inc.Pre-slit injection site and tapered cannula
US6193697B1 (en)1987-03-172001-02-27Baxter International Inc.Pre-slit injection site and tapered cannula
US6213996B1 (en)1988-01-252001-04-10Baxter International Inc.Pre-slit injection site and tapered cannula
US6261270B1 (en)*1998-09-232001-07-17Abbott LaboratoriesSleeve stopper
WO2003099191A1 (en)*2002-05-272003-12-04Fresenius Kabi Deutschland GmbhConnector for packaging containing medical fluids and packaging for medical fluids
US6663599B2 (en)1992-05-062003-12-16Cook IncorporatedHemostasis cannula
US20030233083A1 (en)*2002-06-122003-12-18Vincent HouwaertPort, a container and a method for accessing a port
US20050192537A1 (en)*1992-05-062005-09-01Osborne Thomas A.Hemostasis cannula
US20080011707A1 (en)*2006-04-252008-01-17Naigai Kasei Co., Ltd.Medical cap and a producing method thereof
US20090054865A1 (en)*2004-10-202009-02-26Torsten BrandenburgerClosing cap for containers filled with medical liquids
US20090065465A1 (en)*2007-09-122009-03-12Weimin QianReaction Bottle with Pressure Release
US20100030182A1 (en)*2006-09-292010-02-04Magri PaoloPackaging system for pharmaceutical compositions and kit for intravenous administration
US20100206834A1 (en)*2007-09-122010-08-19Q Labtech LlcChemical reactor with pressure release
US20130102989A1 (en)*2011-10-252013-04-25Target Brands, Inc.Dispensing insert for a medicine containment and dispensing system and associated method
WO2013176587A1 (en)*2012-05-212013-11-28Carmel Pharma AbProtective cap
US20150157836A1 (en)*2008-01-282015-06-11Peter Mats ForsellImplantable drainage device
US9493281B2 (en)2009-05-042016-11-15Carmel Pharma AbSealing barrier arrangement
USD840240S1 (en)2011-10-252019-02-12Cvs Pharmacy, Inc.Bottle
US20190344939A1 (en)*2016-09-282019-11-14Fresenius Kabi Deutschland GmbhSealing cap for a container for holding a medical liquid
US20210251428A1 (en)*2016-12-162021-08-19Steven PippinApparatus and method for introducing a liquid into a sealed food package
CN114191300A (en)*2020-09-022022-03-18单用支持有限公司 container

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4153173A (en)*1978-03-131979-05-08Baxter Travenol Laboratories, Inc.Cap closure and method of producing same
DE3042229C2 (en)*1980-11-081983-10-27B. Braun Melsungen Ag, 3508 Melsungen Insertion device for inserting elongated objects into blood vessels
DE3310265A1 (en)*1983-03-221984-09-27Gerhard 7166 Sulzbach-Laufen Hansen ZIPPER FOR A CONTAINER
JPH0321242Y2 (en)*1985-07-261991-05-09
US5649637A (en)*1994-06-021997-07-22Automatic Liquid Packaging, Inc.Torque-resistant closure for a hermetically sealed container
US5595314A (en)*1994-06-021997-01-21Automatic Liquid Packaging, Inc.Torque-resistant closure for a hermetically sealed container
US7632250B2 (en)2002-05-102009-12-15Tyco Healthcare Group LpIntroducer seal assembly
CA2852090C (en)*2011-10-202016-05-24Becton, Dickinson And CompanyMixing element for container assemblies

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2364126A (en)*1941-12-091944-12-05Cantor AbrahamReceptacle closure
US2847007A (en)*1954-07-191958-08-12Fox Dorothy BrownFluid handling unit and apparatus
US3030955A (en)*1956-10-081962-04-24Baxter Don IncPlastic container
US3368560A (en)*1965-10-071968-02-13Theodore H. GeweckeOutlet fitting for plastic parenteral solution container
US3519158A (en)*1968-09-271970-07-07Dave Chapman Goldsmith & YamasAseptic connector and closure

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2364126A (en)*1941-12-091944-12-05Cantor AbrahamReceptacle closure
US2847007A (en)*1954-07-191958-08-12Fox Dorothy BrownFluid handling unit and apparatus
US3030955A (en)*1956-10-081962-04-24Baxter Don IncPlastic container
US3368560A (en)*1965-10-071968-02-13Theodore H. GeweckeOutlet fitting for plastic parenteral solution container
US3519158A (en)*1968-09-271970-07-07Dave Chapman Goldsmith & YamasAseptic connector and closure

Cited By (78)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4013064A (en)*1975-06-261977-03-22The Kendall CompanyPort means for a liquid transport system
US4219912A (en)*1978-10-101980-09-02Baxter Travenol Laboratories, Inc.Injection site having thermoplastically sealed injection port
US4307766A (en)*1979-05-181981-12-29Terumo CorporationPlastic container for medical liquid
US4294249A (en)*1979-10-181981-10-13Cutter Laboratories, Inc.Swage-molded injection site
US4361253A (en)*1980-08-041982-11-30Instrumentation Laboratory Inc.Liquid transfer device
US4416661A (en)*1981-12-241983-11-22Cutter Laboratories, Inc.Injection site for fluids
US4601703A (en)*1984-01-271986-07-22Intermedicat GmbhInjector for an infusion or transfusion system
WO1985004097A1 (en)*1984-03-131985-09-26Christensen John FAn appliance for the preparation of injectable medicaments
US4665959A (en)*1984-10-151987-05-19Terumo Kabushiki KaishaPlug assembly
US6193697B1 (en)1987-03-172001-02-27Baxter International Inc.Pre-slit injection site and tapered cannula
FR2618682A1 (en)*1987-07-301989-02-03Aguettant LabDevice for closing and connecting containers for infusion liquids
WO1989002399A1 (en)*1987-09-101989-03-23Joseph Parsons Nominees Pty. Ltd.Cap
US6569125B2 (en)1988-01-252003-05-27Baxter International IncPre-slit injection site and tapered cannula
US6447498B1 (en)1988-01-252002-09-10Baxter International Inc.Pre-slit injection site and tapered cannula
US6261266B1 (en)1988-01-252001-07-17Baxter International Inc.Pre-slit injection site and tapered cannula
US6217568B1 (en)1988-01-252001-04-17Edwards Lifesciences CorporationPreslit injection site and tapered cannula for blood sampling
US6213996B1 (en)1988-01-252001-04-10Baxter International Inc.Pre-slit injection site and tapered cannula
US6605076B1 (en)1988-01-252003-08-12Baxter International Inc.Pre-slit injection site and tapered cannula
US5188620A (en)*1988-01-251993-02-23Baxter International Inc.Pre-slit injection site and associated cannula
US5658260A (en)*1988-01-251997-08-19Baxter International Inc.Bayonet lock cannula for pre-slit y-site
US5871500A (en)*1988-01-251999-02-16Baxter International Inc.Pre-slit injection site and tapered cannula
US5211638A (en)*1988-01-251993-05-18Baxter International Inc.Pre-slit injection site
US5797897A (en)*1988-01-251998-08-25Baxter International Inc.Pre-slit injection site and tapered cannula
US5199473A (en)*1988-10-201993-04-06Galloway TrustAseptic fluid transfer apparatus and methods
US5086813A (en)*1988-10-201992-02-11Galloway Edwin JAseptic fluid transfer methods
US5343900A (en)*1988-10-201994-09-06Galloway CompanyNeedle bundle driver and methods
US5269350A (en)*1988-10-201993-12-14Galloway CompanyAseptic fluid transfer apparatus and methods
US4941517A (en)*1988-10-201990-07-17Galloway TrustAseptic fluid transfer apparatus and methods
US4892222A (en)*1988-11-251990-01-09Baxter International Inc.Port assembly for a container
WO1991010459A1 (en)*1990-01-101991-07-25Angeion CorporationHemostasis valve introducer
EP0487712A4 (en)*1990-06-221992-12-02Baxter International Inc.Port and closure assembly including a resealing injection site for a container
US5088995A (en)*1990-06-221992-02-18Baxter International Inc.Port and closure assembly including a resealing injection site for a container
JP3215918B2 (en)1990-06-222001-10-09バクスター、インターナショナル、インコーポレイテッド Port and stopper assembly including resealable injection site for container
US5086783A (en)*1990-10-311992-02-11Sherwood Medical CompanyBlood sampling device
US5246434A (en)*1991-04-261993-09-21Nissho CorporationBlood collecting tube
US5199948A (en)*1991-05-021993-04-06Mcgaw, Inc.Needleless valve
US5776125A (en)*1991-07-301998-07-07Baxter International Inc.Needleless vial access device
US7445611B2 (en)1992-05-062008-11-04Cook IncorporatedHemostasis cannula
US8753317B2 (en)1992-05-062014-06-17Cook Medical Technologies LlcHemostasis cannula
US6663599B2 (en)1992-05-062003-12-16Cook IncorporatedHemostasis cannula
US20040153021A1 (en)*1992-05-062004-08-05Osborne Thomas A.Hemostasis cannula
US20050192537A1 (en)*1992-05-062005-09-01Osborne Thomas A.Hemostasis cannula
US5678713A (en)*1995-01-101997-10-21Pohl Gmbh & Co. KgArrangement on infusion bottles or the like
EP0721897A1 (en)*1995-01-101996-07-17Pohl GmbH & Co. KGDevice for infusion bottles or the like
US6261270B1 (en)*1998-09-232001-07-17Abbott LaboratoriesSleeve stopper
US8118802B2 (en)2002-05-272012-02-21Fresenius Kabi Deutschland GmbhConnector for packaging containing medical fluids and packaging for medical fluids
CN100398084C (en)*2002-05-272008-07-02费森尤斯卡比德国有限公司Connecting piece for medical liquid containing package and package for medical liquid
US20110022024A1 (en)*2002-05-272011-01-27Fresenius Kabi Deutschland GmbhConnector for packaging containing medical fluids and packaging for medical fluids
WO2003099191A1 (en)*2002-05-272003-12-04Fresenius Kabi Deutschland GmbhConnector for packaging containing medical fluids and packaging for medical fluids
US7828787B2 (en)2002-05-272010-11-09Fresenius Kabi Deutschland GmbhConnector for packaging containing medical fluids and packaging for medical fluids
US6994699B2 (en)*2002-06-122006-02-07Baxter International Inc.Port, a container and a method for accessing a port
US20030233083A1 (en)*2002-06-122003-12-18Vincent HouwaertPort, a container and a method for accessing a port
US8211081B2 (en)2004-10-202012-07-03Fresenius Kabi Deutschland GmbhClosing cap for containers filled with medical liquids
US20090054865A1 (en)*2004-10-202009-02-26Torsten BrandenburgerClosing cap for containers filled with medical liquids
US20080011707A1 (en)*2006-04-252008-01-17Naigai Kasei Co., Ltd.Medical cap and a producing method thereof
US9731878B2 (en)*2006-04-252017-08-15Naigai Kasei Co., Ltd.Medical cap and a producing method thereof
US20100030182A1 (en)*2006-09-292010-02-04Magri PaoloPackaging system for pharmaceutical compositions and kit for intravenous administration
US8721616B2 (en)*2006-09-292014-05-13Infa S.A.Packaging system for pharmaceutical compositions and kit for intravenous administration
US20090065465A1 (en)*2007-09-122009-03-12Weimin QianReaction Bottle with Pressure Release
US20100206834A1 (en)*2007-09-122010-08-19Q Labtech LlcChemical reactor with pressure release
US8142736B2 (en)2007-09-122012-03-27Weimin QianReaction bottle with pressure release
US9694165B2 (en)*2008-01-282017-07-04Peter Mats ForsellImplantable drainage device
US20150157836A1 (en)*2008-01-282015-06-11Peter Mats ForsellImplantable drainage device
US9493281B2 (en)2009-05-042016-11-15Carmel Pharma AbSealing barrier arrangement
US9775777B2 (en)2009-05-042017-10-03Carmel Pharma AbSealing barrier arrangement
US8758322B2 (en)*2011-10-252014-06-24Target Brands, Inc.Dispensing insert for a medicine containment and dispensing system and associated method
US20130102989A1 (en)*2011-10-252013-04-25Target Brands, Inc.Dispensing insert for a medicine containment and dispensing system and associated method
USD840240S1 (en)2011-10-252019-02-12Cvs Pharmacy, Inc.Bottle
USD840239S1 (en)2011-10-252019-02-12Cvs Pharmacy, Inc.Bottle
CN104470487A (en)*2012-05-212015-03-25卡麦尔药物股份公司Protective cap
WO2013176587A1 (en)*2012-05-212013-11-28Carmel Pharma AbProtective cap
US9956138B2 (en)2012-05-212018-05-01Carmel Pharma AbProtective cap
US20190344939A1 (en)*2016-09-282019-11-14Fresenius Kabi Deutschland GmbhSealing cap for a container for holding a medical liquid
US11034491B2 (en)*2016-09-282021-06-15Fresenius Kabi Deutschland GmbhSealing cap for a container for holding a medical liquid
US12116188B2 (en)2016-09-282024-10-15Fresenius Kabi Deutschland GmbhSealing cap for a container for holding a medical liquid
US20210251428A1 (en)*2016-12-162021-08-19Steven PippinApparatus and method for introducing a liquid into a sealed food package
US11653682B2 (en)*2016-12-162023-05-23Steven PippinApparatus and method for introducing a liquid into a sealed food package
CN114191300A (en)*2020-09-022022-03-18单用支持有限公司 container

Also Published As

Publication numberPublication date
DE2501428A1 (en)1975-08-28
CA1017707A (en)1977-09-20
AU7704474A (en)1976-07-01
IT1026410B (en)1978-09-20
JPS5813418B2 (en)1983-03-14
JPS50149475A (en)1975-11-29
GB1465041A (en)1977-02-16

Similar Documents

PublicationPublication DateTitle
US3900028A (en)Injection site for sterile medical liquid container
US4892222A (en)Port assembly for a container
US5100394A (en)Pre-slit injection site
US5380315A (en)Mixing apparatus
US5211638A (en)Pre-slit injection site
AU743521B2 (en)A container closure with a frangible seal and a connector for a fluid transfer device
US6599273B1 (en)Fluid transfer device and method of use
US5368586A (en)Closure for a drug-vial
JP4729022B2 (en) Sliding reconstitution for diluent containers
US6874522B2 (en)Luer-actuated solution path connector with membrane and container using the connector and a method for establishing fluid communication with the container
US4219912A (en)Injection site having thermoplastically sealed injection port
AU2004224795A1 (en)Connector for packings containing medical liquids, and corresponding packing for medical liquids
CA2261428A1 (en)Medicament container stopper with integral spike access means
US6179821B1 (en)Membrane port for a container
US4227954A (en)Method for sealing container cap parts
US3938519A (en)Medical liquid container with a toggle film leak tester and method of leak testing with same
JP3070044B2 (en) Infusion container with communication means
JP2578425B2 (en) Plastic container with rubber stopper
JPH1033635A (en) Medical needle and drug dissolution kit
JP2607232Y2 (en) Infusion container
JPH08224315A (en)Connecting device
JPH03267063A (en)Plastic blow bag for liquid medicine
JPS60163902U (en) blood sampling equipment
IE903852A1 (en)Pre-slit injection site

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:KENDALL MCGAW LABORATORIES, INC., 2525 MCGAW AVENU

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST. EFFECTIVE NOVEMBER 26, 1985.;ASSIGNOR:AMERICAN HOSPITAL SUPPLY CORPORATION, A CORP OF IL;REEL/FRAME:004600/0460

Effective date:19851126

Owner name:KENDALL MCGAW LABORATORIES, INC., A CORP OF OH,CAL

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMERICAN HOSPITAL SUPPLY CORPORATION, A CORP OF IL;REEL/FRAME:004600/0460

Effective date:19851126

ASAssignment

Owner name:WELLS FARGO BANK, N.A.

Free format text:SECURITY INTEREST;ASSIGNOR:MCGAW, INC., A CORP. OF OH;REEL/FRAME:005477/0809

Effective date:19901022

ASAssignment

Owner name:KENDALL MCGAW LABORATORIES, INC. AN OH CORPORAT

Free format text:RELEASED BY SECURED PARTY;ASSIGNOR:MANUFACTURERS HANOVER TRUST COMPANY;REEL/FRAME:005709/0001

Effective date:19901015

ASAssignment

Owner name:KENDALL MCGAW LABORATORIES, INC., AN OH CORP.

Free format text:RELEASED BY SECURED PARTY;ASSIGNOR:MANUFACTURERS HANOVER TRUST COMPANY;REEL/FRAME:005515/0206

Effective date:19901015

ASAssignment

Owner name:MCGAW, INC., MORAINE, MONTGOMERY COUNTY, A CORP. O

Free format text:MERGER;ASSIGNOR:MG ACQUISITION CORP. A CORP. OF DE (MERGED TO) KENDALL MCGAW LABORATORIES, INC., A CORP. OF OHIO;REEL/FRAME:005640/0520

Effective date:19910205

STCFInformation on status: patent grant

Free format text:PATENTED FILE - (OLD CASE ADDED FOR FILE TRACKING PURPOSES)

ASAssignment

Owner name:GENERAL ELECTRIC CAPITAL CORPORATION, A NEW YORK C

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:MCGAW, INC., A DELAWARE CORP.;REEL/FRAME:006073/0600

Effective date:19920401

ASAssignment

Owner name:MCGAW, INC. A CORP. OF DELAWARE

Free format text:SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK, N.A.;REEL/FRAME:006139/0057

Effective date:19920401


[8]ページ先頭

©2009-2025 Movatter.jp